Trial site
Orszagos Onkologiai Intezet
- 11running trials
- 16closed trials
The trials here
What the 27 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer5 trials
- Lung cancer4 trials
- Melanoma4 trials
- Bladder cancer3 trials
- Kidney cancer3 trials
- Ovarian cancer3 trials
- Triple-negative breast cancer3 trials
- Head and neck cancer2 trials
- Liver and biliary tract cancer2 trials
- Prostate cancer2 trials
- Cervical cancer1 trial
- Colorectal cancer1 trial
- and 3 more
- Phase
- Phase 321 trials
- Phase 25 trials
- Phase 1/21 trial
- Status
- Completed13 trials
- Active, not recruiting5 trials
- Recruiting5 trials
- Terminated3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Pfizer4 trials
- Hoffmann-La Roche3 trials
- Amgen2 trials
- Incyte Corporation2 trials
- and 11 more
Running trials
Recruiting
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recruiting
Recruiting
Recruiting
Active, not recruiting
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Active, not recruiting
Active, not recruiting
Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Head and neck cancer1 recruiting
- Lung cancer1 recruiting
- Multiple myeloma1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Terminated
Terminated
Terminated
Completed
Completed
Completed
Completed
Completed
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
Completed
Completed
Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)
Completed
Completed
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Completed
Completed
PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026